Cannell & Spears’s Xylem XYL Stock Holding History

Cannell & Spears’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	126,985 +9,570	+8%	+$1.1M	0.27%	87
2026 Q1	$14M	Sell	117,415 -72,565	-38%	-$9.52M	0.28%	85
2025 Q4	$25.9M	Sell	189,980 -27,853	-13%	-$4.01M	0.48%	53
2025 Q3	$32.1M	Sell	217,833 -3,812	-2%	-$529K	0.61%	49
2025 Q2	$28.7M	Buy	221,645 +7,300	+3%	+$884K	0.58%	52
2025 Q1	$25.6M	Buy	214,345 +110,051	+106%	+$13.6M	0.55%	61
2024 Q4	$12.1M	Sell	104,294 -329,736	-76%	-$41.7M	0.25%	87
2024 Q3	$58.6M	Buy	434,030 +360,874	+493%	+$48.3M	1.15%	21
2024 Q2	$9.92M	Sell	73,156 -44,060	-38%	-$5.99M	0.21%	95
2024 Q1	$15.1M	Buy	+117,216	New	+$14.2M	0.31%	83

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Cannell & Spears's XYL Position: Q2 2026 in Review

Cannell & Spears increased its Xylem (XYL) stake by 8.2% in Q2 2026, buying an estimated $1.1M and bringing the position to 126,985 shares worth $15M. The position accounts for 0.27% of the portfolio, ranked #87.

Cannell & Spears first reported a position in XYL in Q1 2024 and has held it in 10 quarters since. The position peaked at $58.6M in Q3 2024. 1,097 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Cannell & Spears held 126,985 shares of Xylem worth $15M as of Q2 2026.
Cannell & Spears bought 9,570 Xylem shares in Q2 2026, an estimated $1.1M.
Xylem made up 0.27% of Cannell & Spears's portfolio in Q2 2026, its #87 holding.
Cannell & Spears first reported a position in Xylem in Q1 2024 and has held it in 10 quarters since.
Cannell & Spears's Xylem position peaked at $58.6M in Q3 2024.
1,097 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.